AlloClae Breast Treatment Faces Legal Battle | New York City News

A controversial cosmetic treatment called alloClae—cadaver-derived fat injections for breast enlargement—is sparking a legal firestorm after New York shut it down, calling the company’s tactics “smuggling” and citing safety concerns. Tiger Aesthetics, the maker, argues it’s federally approved and sterile, dismissing state interference. The company lost licenses over alleged character issues and admitted to shipping product from a facility they previously denied having. A patient reported painful lumps and fat necrosis after using alloClae, while the company insists complications are rare and blames technique—not product—for issues. Talks with New York are underway, but if no deal is reached, the battle heads back to court. Listen in comfort:Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn. Advertise on DNN:[email protected] This is an automated, high-level news summary based on public reporting.Report issues to [email protected]. View sources & latest updates:https://sources.thednn.ai/2dfdfe518a42d7ca